Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation "sifap2"


Phase N/A Results N/A

Summary of Purpose

New studies indicate that in about 1 - 2 percent of the younger stroke patients the cause could have been an undiagnosed genetic disease, the so called Fabry disease. In this case certain fat molecules are not digested and broken down by the body - but remain in the cells. These fat molecules build up to dangerous levels, which start to damage the body, because they accumulate e.g. in the walls of the blood...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 July 2017.

1 Jul 2007 19 Dec 2006 1 Jun 2019 1 Jun 2019 1 Jul 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample